Research on the Pathogenesis of Fungal Infections
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (30 November 2024) | Viewed by 2987
Special Issue Editor
Interests: Candida species; multidrug-resistant fungi; anti-fungal drugs; modulation of the immune response; intestinal inflammation; gut microbiota; anti-yeast glycan antibodies; fungal cell wall; intravenous immunoglobulin (IVIg); TLRs
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The first volume of the Special Issue “Research on the Pathogenesis of Candida albicans and Other Candida Species” was published in 2022. It was a successful Issue with five published papers and has encouraged us to open a second volume with the same topic.
As a continuation of the Special Issue published in 2022, this second volume aims to update the current knowledge of the pathogenesis of Aspergillus and Candida species in patients with fungal infection and the rise of new multidrug-resistant fungi, the fungal cell wall, and new antifungal drugs. Topics may include but are not limited to:
- Aspergillosis
- Mold
- Aspergillus fumigatus
- Fungal skin infection
- Malassezia
- dermatitis
- Candida albicans
- Candida glabrata
- Candida auris
- Candida species
- multidrug-resistant fungi
- anti-fungal drugs
- candidiasis
- immune response
- intestinal inflammation, gut microbiota
- anti-yeast glycan antibodies
- fungal cell wall
- chitin
- β-glucans
- mannans
You may choose our Joint Special Issue in Journal of Fungi.
Dr. Samir Jawhara
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
